1.
Salazar Gómez L, Grisales Negrete JP. Molecular and clinical evidence of the cardiovascular benefit of SGLT2 inhibitors: State of the art. Med UPB. 2022;41(2):145-156. doi:10.18566/medupb.v41n2.a07